Unmet Needs in Retinal Diseases: Dry AMD and Rare Disorders Push the Market Toward Novel Solutions
While the retinal drugs market has made strides in treating wet AMD and proliferative diabetic retinopathy, significant unmet needs persist, particularly for dry age-related macular degeneration (dry AMD) and rare inherited retinal disorders (IRDs). These conditions affect millions but lack effective therapies, creating a pressing need for innovation. Addressing these gaps not only improves...
0 Commenti
0 condivisioni
39 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt